Common indications Cardiogenic shock Refractory cardiac arrest Impossible weaning from cardiopulmonary bypass during cardiac surgery Myocarditis Intoxication or sepsis with severe myocardial depression “Primary graft failure” after heart or lung…
Fig. 35.1 Time course of platelets, fibrinogen, D-dimer % change from baseline between ML change-outs (black vertical lines) during a prolonged VV ECMO treatment, showing “circuit coagulation activation” A significant…
Advantages Disadvantages Not influenced by weather Shorter maximum distance coverage Available night and day Safety of transportation negatively affected by street roughness, other vehicles, traffic Airports/heliport and secondary transportation not…
Fig. 34.1 Continuous multimodal neuromonitoring during postcardiotomy ECMO; on the upper side, the neurophysiological, NIRS, and TCD monitoring are highlighted 34.3 Neurophysiological Monitoring of Brain Function Brain function can be…
Fick principle Pulsed Doppler technology Echocardiography Pulse contour analysis Bioimpedance Bioreactance 32.2.1.2 SvO2 The maintenance of the adequate tissue oxygen supply–demand balance is fundamental in the critically ill patients on…
Fig. 5.1 Central cannulation. Ao aorta, PV pulmonary vein, LA left atrium, RV right ventricle, LV left ventricle 5.2.2 Surgical Technique The site for the cannulation of the aorta is…
Fig. 24.1 CO2 removal at different levels of sweep gas flow (SGF) during awake vvECMO. Increasing levels of SGF were associated with an increase of extracorporeal CO2 removal and a…
EVLP donors Year DBD DCD EVLP → Lung transplant Ingemansson Ann Thor Surg 2009 × Yes Pego-Fernandez Rev Bras Cir Cardiovasc 2010 × No Cypel New Engl J Med 2011 ×…
Reference Year No. of patients Bridge duration (days) Type of ECMO Successful bridge (%) 1-year survival (%) Fischer et al. [8] 2006 12 15 ± 8 (4–32) AV 83 80 Cypel et…
Pro-hemorrhagic factors Pro-thrombotic factors Excessive heparin anticoagulation Inadequate heparin anticoagulation Consumption of coagulation factors Acquired antithrombin deficiency Low fibrinogen levels Protein C-S complex consumption Thrombocytopenia Tissue factor pathway inhibitor consumption…
